2021 · Oncology letters · open access
Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia
Östensson et al.
The finding, in our words
Self-sampled vaginal swabs and urine can identify women with recurrent CIN2+ after treatment for high-grade CIN, with vaginal self-sampling showing high sensitivity and substantial agreement with clinician sampling, while urine shows moderate agreement; this supports home-based follow-up to maximise participation.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.